Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × napabucasin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 17 NETWORK 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Cyclophosphamide 1730 Radiotherapy 1683 Cisplatin 1534 Carboplatin 1300 Gemcitabine 1207 Paclitaxel 1108 Bevacizumab 1083 Docetaxel 1051 pembrolizumab 1042 Capecitabine 989 Oxaliplatin 979 Fluorouracil 917 Dexamethasone 820 Magnetic Resonance Spectroscopy 816 Nivolumab 787 Rituximab 776 Drug Therapy 756 Surveys and Questionnaires 749 Doxorubicin 705 Etoposide 698 Radiosurgery 688 Blood Specimen Collection 674 Irinotecan 652 Cytarabine 630 fludarabine 611 Leucovorin 575 Surgical Procedures, Operative 535 Lenalidomide 522 Radiation 489 Biopsy 486

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02851004 2021-09-05

Special Combination of BBI608 and Pembrolizumab

National Cancer Center Hospital East

Phase 1/2 Terminated

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡